aidsmap: "Intensifying effective HIV therapy with the addition of an extra drug that crosses the blood-brain barrier does not reduce residual levels of viral replication in cerebrospinal fluids or the blood, an international team of investigators report in the online edition of the Journal of Acquired Immune Deficiency Symdromes.
"The researcher also found that patients continued to have evidence of immune activation and inflammation in the brain."
0 comments:
Post a Comment